The Senate has passed a drug recall bill amid criticism of pharmaceutical companies as second only to “big oil” as a powerful Parliament Hill lobby. The legislation followed Health Canada complaints of obstructionism by drug firms in restricting medicine deemed a health risk: ‘Next to big oil, nobody’s bigger’.
This content is for Blacklock’s Reporter members only. Please login to view this content. (Register here.)
